BIOPHTA

https://lnkd.in/dB466S9H

👁️ Get to know BIOPHTA’s CEO, Jean GARREC! BIOPHTA believes there must be a better alternative to treating eye problems than needles or injections for the 36 million people suffering from opthalmogical disorders worldwide. Instead, BIOPHTA has developed a new biopolymer tablet that applies to the eye like a contact lens, allowing for treatment to be applied continuously over a week without injections. Deep dive here: https://lnkd.in/dJScfWby Florian Denis

🚀 Our CTO, Jean Cuiné, will be speaking on novel approaches in ocular drug delivery at the upcoming BioPharma Formulation & Delivery Nexus Conference in London🚀 Jean will be sharing his insights on the challenges of ocular drug delivery and how patient quality of life and treatment efficacy can be improved by innovation in drug delivery. 📅 14 & 15 November 📍 Renaissance London Heathrow Hotel, London, Uk 👉 https://lnkd.in/dPm5JEQC #OcularDrugDelivery #Innovation #DrugDeliverySolutions

👉 Meet our CTO Jean Cuiné at CPhI! #biotech #ophthalmology #drugdelivery #glaucoma #retina

📢 BIOPHTA has been awarded during The European Society of Cataract and Refractive Surgeons (ESCRS) 2024 congress ! 🏆 👉 Jean GARREC gave a lecture on BIOPHTA’s technology and innovation during the 2024 ESCRS annual congress that was rewarded by the ESCRS President as well as the US ASCRS President. 🌟 It’s a great pride and honor for BIOPHTA’s entire team to be distinguished by two of the world's most renowned Eye Doctors' scientific societies. 👨⚕️ Thank you, Vance Thompson, Filomena Ribeiro, Diana Saraceni, Shahzad Malik as well as Sorcha Ní Dhubhghaill for mentoring us. 🙏 We are looking forward to ESCRS 2025 ! 📆 #ophthalmology #glaucoma #biotech #DME #retina #drugdelivery

𝟏𝟎 𝐩𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐡𝐞𝐥𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐛𝐥𝐢𝐧𝐝 𝐚𝐧𝐝 𝐯𝐢𝐬𝐮𝐚𝐥𝐥𝐲 𝐢𝐦𝐩𝐚𝐢𝐫𝐞𝐝 Antonio L. Escárzaga, EU-Startups shines a light on 10 promising European startups that are making significant contributions to assist the blind and visually impaired: 1️⃣ BIOPHTA 2️⃣ 2biped robotics 3️⃣ DIVE Medical 4️⃣ D-Sight S.L. 5️⃣ dotLumen 6️⃣ Ilasis Laser 7️⃣ Novis Games 8️⃣ OKKO Health 9️⃣ Regensight 🔟 WEWALK read on: https://lnkd.in/d4MJSjrH

Did you know that in Europe, visual impairments, including blindness and partial sight, affect a significant portion of the population, with an estimated 30 million people across the continent experiencing some form of sight loss? 👁️✨ In this article, we shine a light on 10 promising European startups that are making significant contributions to assist the blind and visually impaired. From smart mobility aids to advanced medical devices and accessible software, vision technology is rapidly evolving to empower individuals with better tools for daily living 🚀 BIOPHTA, biped robotics, DIVE Medical, D-Sight S.L., dotLumen, Ilasis Laser, Novis Games, OKKO Health, Regensight, WeWALK https://lnkd.in/d4HTtq8P

🚀 Exciting News! 🚀 BIOPHTA has successfully closed a €6.5 million Seed round to advance our revolutionary technology for treating eye diseases to clinical stage. This significant milestone was made possible with the support of top European VCs – UI Investissement (via the Pertinence Invest 2 Fund, advised by Merieux Equity Partners), Elaia, GO CAPITAL, with participation from one major ophthalmology player, Unither Pharmaceuticals and HTL Biotechnology, the global leader in production and development of pharma grade biopolymers. Our first program targets Glaucoma (Phase 1 in 2025), addressing a market valued at $8.7 billion, while our second program focuses on Macular Edema (Phase 1 in 2026), a $9.6 billion market. With these programs, BIOPHTA aims to combat the two leading causes of blindness. Thank you to our investors and partners for believing in our vision. Together, we are on the path to transforming eye disease treatment! 🌟 Special thanks to Alexandre Boulay, Valérie Calenda, Florian Denis, Valentin T. Fleury and Nathalie Masson. #Biotech #Investment #Innovation #Ophthalmology #EyeHealth #BIOPHTA #VCFunding #Glaucoma #MacularEdema Read the full press release: https://lnkd.in/eDUdhgDX

📢 BIOPHTA will be attending the 2024 BIO international convention next week (June3-6) 👉Book a meeting now 📆 with Jean GARREC in San Diego and join us on our mission to fight blindness 👁 #BIOUS #biotech #ophthalmology #glaucoma #biotechnology #retina #glaucoma #drugdelivery

👉 Jean Cuiné, BIOPHTA's Chief Technology Officer will be attending ARVO 2024 in Seattle! 👉 Meet with Jean Cuiné and join us on our mission to fight blindness ! 👁 #ophthalmology #biotechnology #retina #glaucoma #drugdelivery https://lnkd.in/ecEhw9QH